Effects of miR-335-5p targeting G6PD on proliferation and apoptosis of colon cancer cells

doi:10.12047/j.cjap.6090.2021.041

Abstract

Abstract: Objective: To investigate the effects of miR-335-5p targeting glucose-6-phosphate dehydrogenase (G6PD) on the proliferation and apoptosis of colon cancer cells. Methods: Normal colon cell group, blank control group, NC group and miRNA-335-5p mimic group were set up. Colonic epithelial cells (IEC) and human colon cancer cells SW480 were cultured in vitro, and the cells in the NC group and miRNA-335-5p mimic group cells were transfected. RT-qPCR was used to detect the expression levels of miR-335-5p and G6PD mRNA in each group of cells. The targeting effect of miR-335-5p on G6PD was verified by Double Luciferase Report experiment. MTT assay was used to detect cell proliferation. Flow cytometry was used to detect the apoptosis rate. The expressions of G6PD, Bax, Bcl-2 and caspase-3 were detected by Western blot. Results: Compared with normal colon cells, the relative expression levels of miR-335-5p in SW480 cells of colon cancer in the blank control group and NC group were decreased, and the relative expression level of G6PD mRNA was increased (P＜0.05); compared with the blank control group and NC group, the expression level of miR-335-5p in miR-335-5p mimic group was increased significantly, and the expression of G6PD mRNA was decreased significantly (P＜0.05). Compared with the blank control group and NC group, the proliferative activity of colon cancer SW480 cells in miR-335-5p mimic group was decreased significantly, and the apoptosis rate was increased significantly (P＜0.05). The relative activity of luciferase in miR-335-5p mimic + WT-G6PD 3 '- UTR group was lower than that in miR-335-5p NC + WT-G6PD 3' - UTR group (P＜0.05). Compared with the blank control group, the relative expression levels of G6PD and bcl-2 protein in miR-335-5p mimic group were decreased significantly, and the expression levels of Bax and caspase-3 protein were increased significantly (P＜0.05). Conclusion: MiR-335-5p may inhibit the proliferation and promote apoptosis of colon cancer cells by targeting G6PD.

Key words: microRNA-335-5p, glucose-6-phosphate dehydrogenase, colon cancer, cell proliferation, apoptosis

CLC Number:

R363
R735.3

FAN Xiao-qun, LI Huan, ZHU Hua-xiong, HUANG Jian-ping, HE Lyu-fen. Effects of miR-335-5p targeting G6PD on proliferation and apoptosis of colon cancer cells[J]. CJAP, 2021, 37(4): 402-406.

References 21

[1]	Onyoh EF, Hsu WF, Chang LC, et al. The rise of colorectal cancer in Asia: Epidemiology, screening, and management[J]. Curr Gastroenterol Rep, 2019, 21(8): 36-36.
[2]	Pazzaglia L, Leonardi L, Conti A, et al. miR-196a expression in human and canine osteosarcomas: A comparative study[J]. Res Vet Sci, 2015, 99(11):112-119.
[3]	Ju HQ, Lu YX, Wu QN, et al. Disrupting G6PD-mediated Redox homeostasis enhances chemosensitivity in colorectal cancer[J]. Oncogene, 2017, 36(45): 6282-6292.
[4]	伍学翠, 赵云, 李聪, 等. miRNA在异丙肾上腺素诱导大鼠心肌肥厚中的表达及生物信息学分析[J]. 中国应用生理学杂志, 2019, 35(5): 476-480.
[5]	Slattery ML, Herrick JS, Mullany LE, et al. An evaluation and replication of miRNAs with disease stage and colorectal cancer-specific mortality[J]. Int J Cancer, 2015, 137(2): 428-438.
[6]	Banerjee A, Pathak S, Subramanium VD, et al. Strategies for targeted drug delivery in treatment of colon cancer: current trends and future perspectives[J]. Drug Discov Today, 2017, 22(8): 1224-1232.
[7]	王倩, 袁莉莉, 范文涛.基于GEO和TCGA数据库分析促癌基因INHBA和抑癌基因CLCA4、CA4在结直肠癌中表达[J]. 中国应用生理学杂志, 2019, 35(3): 279-282.
[8]	Rojas F, Hernandez ME, Silva M, et al. The oncogenic response to MiR-335 is associated with cell surface expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) activity[J]. PloS One, 2015, 10(7): e0132026.
[9]	Alipoor SD, Adcock IM, Garssen J, et al. The roles of miRNAs as potential biomarkers in lung diseases[J]. Eur J Pharmacol, 2016, 791(1): 395-404.
[10]	O'Brien J, Hayder H, Zayed Y, et al. Overview ofmicroRNA biogenesis, mechanisms of actions, and circulation[J]. Front Endocrinol, 2018, 9(3): e402-e413.
[11]	Li H, Xie S, Liu M, et al. The clinical significance of downregulation of mir-124-3p, mir-146a-5p, mir-155-5p and mir-335-5p in gastric cancer tumorigenesis[J]. Int J Oncol, 2014, 45(6): 197-208.
[12]	Wang K, Wei J, Yan S, et al. LncRNA RP11-436H11.5, functioning as a competitive endogenous RNA, upregulates BCL-W expression by sponging miR-335-5p and promotes proliferation and invasion in renal cell carcinoma[J]. Molecular Cancer, 2017, 16(1): e166-e175.
[13]	Wang F, Li L, Piontek K, et al. Exosome miR-335 as a novel therapeutic strategy in hepatocellular carcinoma[J]. Hepatology, 2018, 67(3): 940-954.
[14]	Gougelet A. Exosomal microRNAs as a potential therapeutic strategy in hepatocellular carcinoma[J]. Hepatology, 2018, 10(11): 5-9.
[15]	Nóbrega-Pereira S, Fernandez-Marcos PJ, Brioche T, et al. G6PD protects from oxidative damage and improves healthspan in mice[J]. Nat Commun, 2016, 7(1): e10894-e10902.
[16]	Yan G, Wang X, Yang M, et al. Long non-coding RNA TUG1 promotes progression of oral squamous cell carcinoma through upregulating FMNL2 by sponging miR-219[J]. Am J Cancer Res, 2017, 7(9): e1899-e1910.
[17]	Liu R, Guo H, Lu S. MiR-335-5p restores cisplatin sensitivity in ovarian cancer cells through targeting BCL2L2[J]. Cancer Med, 2018, 7(9): 4598-4609.
[18]	Zhang D, Yang N. MiR-335-5p inhibits cell proliferation, migration and invasion in colorectal cancer through downregulating LDHB[J]. J Buon, 2019, 24(3): 1128-1136.
[19]	Belfield KD, Tichy EM. Review and drug therapy implications of glucose-6-phosphate dehydrogenase deficiency[J]. Am J Health Syst Pharm, 2018, 75(3): 97-104.
[20]	Kalnoky M, Bancone G, Kahn M, et al. Cytochemical flow analysis of intracellular G6 PD and aggregate analysis of mosaic G6 PD expression[J]. Eur J Haematol, 2018, 100(3): 294-303.
[21]	Thomas J, Ohtsuka M, Pichler M, et al. MicroRNAs: clinical relevance in colorectal cancer[J]. Int J Mol Sci, 2015, 16(12): 28063-28076.